Phillip Chan | executive |
Kathleen Bloch | executive |
Vincent Capponi | executive |
Efthymios Deliargyris | executive |
Peter Mariani | executive |
Michael Sarcone | analyst |
Yuan Zhi | analyst |
Thomas Kerr | analyst |
Xun Lee | analyst |
Ladies and gentlemen, good afternoon, and welcome to the CytoSorbents Second Quarter 2024 Financial and Operating Results Conference Call. [Operator Instructions] Please be advised that the call will be recorded at the company's request. At this time, I'd like to turn the call over to our moderator, Eric Ribner. Please go ahead, Mr. Ribner.